Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal Fentanyl vs IV Morphine for Sickle Cell Pain
NCT03682211Phase 4Completed
- Sponsor
- University College Dublin
- Start
- Dec 2012
- Primary completion
- Nov 2013
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of fentanyl citrate nasal spray in sickle cell disease (SCD) (2 arms), sponsored by University College Dublin. Primary endpoint: Pain score as measured using the FLACC scale and Manchester Pain Ruler at 10 minutes. Started Dec 2012; status: completed.
02
Drugs
fentanyl citrate nasal spray
03
Conditions
sickle cell disease (SCD)
Beyond the preview
Go deeper on NCT03682211.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03682211.